Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension
0Citations signalées
2Institutions associées
1Pays d’affiliation
Résumé fourni par la source
https://bit.ly/4sMY3aF.
Institutions
Sujets associés
Pulmonary Hypertension Research and TreatmentsHeart Failure Treatment and ManagementTransplantation: Methods and Outcomes